Home Immunology & Inflammation NADPH-oxidase inhibitor - ROS inhibitor - Apoptosis related inhibitor GSK2795039 For research use only.

GSK2795039

GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) with pIC50 of 6.57 for NOX2-mediated activation of HRP/Amplex Red. GSK2795039 inhibits reactive oxygen species (ROS) production, NADPH consumption and reduces apoptosis.

GSK2795039 Chemical Structure

GSK2795039 Chemical Structure

CAS No. 1415925-18-6

Purity & Quality Control

Batch: S897401 DMSO]90 mg/mL]false]Ethanol]20 mg/mL]false]Water]Insoluble]false Purity: 99.77%
99.77

GSK2795039 Related Products

Biological Activity

Description GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) with pIC50 of 6.57 for NOX2-mediated activation of HRP/Amplex Red. GSK2795039 inhibits reactive oxygen species (ROS) production, NADPH consumption and reduces apoptosis.
Targets
ROS [2] NADPH [2] NOX2 (HRP/Amplex Red) [1]
(Cell-based assay)
6.57(pIC50)
In vitro
In vitro

GSK2795039 inhibits both the formation of ROS and the utilization of the enzyme substrates, NADPH and oxygen, in a variety of semirecombinant cell-free and cell-based NOX2 assays. GSK2795039 inhibits NOX2 in an NADPH competitive manner and is selective over other NOX isoforms, xanthine oxidase, and endothelial nitric oxide synthase enzymes.[1]
Cell Research Cell lines NOX isoform-specific cells, PBMCs, PMNs, HL60 cells
Concentrations 3.16 nM, 10 nM, 31.6 nM, 100 nM, 316 nM, 1μM, 3.16 μM, 10 μM, 31.6 μM, 100μM
Incubation Time 10 min, 20 min, 30 min, 40 min, 50 min, 60 min
Method

For Amplex Red/HRP assay, cells are preincubated with the GSK2795039 for 10 min at room temperature in PerkinElmer black 96-well microplates at 50,000 cells per well, after which the reaction mixture is added to a final concentration of 25 μM of Amplex Red and 0.05 U/ml of HRP in HBSS. NOX enzymes are activated via 100 nM PMA (NOX1, NOX2), 1 μg/ml tetracycline for 24-h activation of inducible genes (NOX3, NOX4), and 1 μM Ca2+ ionophore ionomycin (NOX5).
In Vivo
In vivo

Following systemic administration in mice, GSK2795039 abolishes the production of ROS by activated NOX2 enzyme in a paw inflammation model. GSK2795039 shows activity in a murine model of acute pancreatitis, reducing the levels of serum amylase triggered by systemic injection of cerulein.[1]
Animal Research Animal Models Male Sprague-Dawley (SD) rats, C57BL6/J mice, gp91phox knockout mice
Dosages 2–100 mg/kg
Administration IP

Chemical Information & Solubility

Molecular Weight 450.56 Formula

C23H26N6O2S
CAS No. 1415925-18-6 SDF --
Smiles CC(C)N1C=C(C2=C(C=CN=C21)NS(=O)(=O)C3=NN(C=C3)C)C4=CC5=C(CCN5C)C=C4
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 90 mg/mL ( (199.75 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 20 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy GSK2795039 | GSK2795039 supplier | purchase GSK2795039 | GSK2795039 cost | GSK2795039 manufacturer | order GSK2795039 | GSK2795039 distributor